The MED-EL Cochlear Implant Systems are intended to evoke auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.
Cochlear implantation is a prescription treatment, if you believe you are a potential candidate, contact your physician or hearing healthcare center for a pre-operative assessment according to the local professional standards. Certain medical conditions, including auditory nerve damage, inner ear malformations, middle ear infection, cranial malformation and allergies to the implant materials may constitute some contraindication(s).
To obtain the optimal benefit from the implant, the prospective implant users and their families shall be highly motivated and have realistic expectations about the expected benefit of the implant and shall understand the importance of returning to the implant center for regular audio processor programming, assessment sessions and training.
Risks associated with cochlear implantation include, but are not limited to: complications from general anesthesia, post-operative surgical complications (dizziness, increased vertigo, delay of healing of the scar, impairment of the sense of taste, infection including rare instances of meningitis, potential for swallowing difficulties, numbness, increased tinnitus, stimulation of the facial nerve, temporary pain and uncomfortable sounds during stimulation), potential loss of residual hearing, need for additional surgery in case of damage to the implant. After implantation, some limitations regarding magnetic resonance imaging will apply.